Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Best Biotech Stocks To Watch Now – March 12th
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
MoneyWeek on MSN7d
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a ...
The Motley Fool29d
The Ultimate Healthcare Stock to Buy With $500 Right Now
That's encouraging, considering that Vertex's current top-selling CF drug Trikafta/Kaftrio raked in revenue of $10.2 billion last year. Adding to the excitement, the FDA approved Vertex's acute ...
The Motley Fool22d
2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
Vertex markets all of them. Its top product, Trikafta/Kaftrio, raked in sales of $10.2 billion last year. The company won U.S. Food and Drug Administration (FDA) approval in December 2024 for ...
Yahoo Finance29d
The Ultimate Healthcare Stock to Buy With $500 Right Now
That's encouraging, considering that Vertex's current top-selling CF drug Trikafta/Kaftrio raked in revenue of $10.2 billion last year. Adding to the excitement, the FDA approved Vertex's acute pain ...